| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.84B | 77.28B | 78.23B | 78.39B | 79.34B | 65.98B |
| Gross Profit | 13.68B | 12.49B | 13.61B | 11.35B | 15.38B | 14.36B |
| EBITDA | 9.99B | 8.83B | 10.10B | 7.64B | 11.28B | 10.56B |
| Net Income | 3.08B | 1.42B | 3.14B | 4.33B | 7.95B | 7.77B |
Balance Sheet | ||||||
| Total Assets | 96.79B | 93.41B | 104.16B | 102.54B | 104.94B | 95.89B |
| Cash, Cash Equivalents and Short-Term Investments | 5.91B | 6.02B | 5.95B | 7.87B | 8.91B | 9.78B |
| Total Debt | 13.84B | 13.82B | 17.07B | 18.55B | 21.47B | 18.00B |
| Total Liabilities | 23.14B | 22.39B | 30.48B | 31.10B | 35.72B | 31.56B |
| Stockholders Equity | 73.66B | 71.03B | 73.68B | 71.44B | 69.19B | 64.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.74B | 1.66B | 3.98B | 1.74B | 2.53B |
| Operating Cash Flow | 0.00 | 14.57B | 5.96B | 8.78B | 6.28B | 5.25B |
| Investing Cash Flow | 0.00 | -5.58B | -4.85B | -4.67B | -4.59B | -2.21B |
| Financing Cash Flow | 0.00 | -8.91B | -3.06B | -5.24B | -2.68B | -2.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥354.25B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
74 Outperform | ¥396.63B | 9.05 | 6.16% | 2.99% | -0.02% | -40.45% | |
74 Outperform | ¥215.58B | 14.50 | 6.87% | 5.25% | -1.43% | 171.44% | |
70 Outperform | ¥104.34B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
67 Neutral | ¥186.49B | 11.58 | 5.06% | 1.80% | 4.10% | 152.90% | |
63 Neutral | ¥61.00B | 33.48 | 1.97% | 3.23% | 5.34% | -60.38% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |